Loading clinical trials...
Loading clinical trials...
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients
Conditions
Interventions
HM II (HeartMate II LVAD)
OMM (Optimal Medical Management)
Locations
52
United States
Baptist Medical Center
Little Rock, Arkansas, United States
Cedars Sinai Medical Center
Beverly Hills, California, United States
Keck Medical Center of USC
Los Angeles, California, United States
Sharp Memorial Hospital
San Diego, California, United States
Stanford University
Stanford, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Start Date
October 1, 2011
Primary Completion Date
March 1, 2016
Completion Date
June 1, 2016
Last Updated
June 24, 2022
NCT07083011
NCT07550790
NCT07037459
NCT06148935
NCT06874556
NCT06741436
Lead Sponsor
Abbott Medical Devices
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions